Skip to main content

Genetics disease risk

Genetic, environmental factors in disease risk, new insights found




Environmental factors may play a larger role in disease risk than previously thought, overshadowing genetic contributions, a study by researchers at Penn State College of Medicine reveals.

Published in the journal Nature Communications, the research shows that lifestyle and environmental factors, such as air pollution, can significantly influence disease risk, offering more opportunities for mitigation.

“We’re trying to disentangle how much genetics and environment influences the development of disease,” said Bibo Jiang, assistant professor of public health sciences.

The team used a novel spatial mixed linear effect model, combining genetics and geolocation data, to analyse disease risks.

Co-senior author Dajiang Liu emphasised the importance of separating environmental influences from genetic factors, “If we can tease apart these shared environments, what’s remaining could more accurately reflect genetic heritability of disease.”

Using data from IBM MarketScan and environmental data, the researchers re-evaluated the genetic contributions to various diseases.

For example, the genetic risk of type 2 diabetes was recalibrated from 37.7 per cent to 28.4 per cent, highlighting a greater role for environmental factors. Similarly, the genetic contribution to obesity risk decreased from 53.1 per cent to 46.3 per cent.

The study also distinguished the effects of specific pollutants, such as PM2.5 and NO2, on health conditions. NO2 was found to directly influence conditions like high cholesterol and diabetes, whereas PM2.5 impacted lung function and sleep disorders.

This research suggests that understanding the balance between genetic and environmental factors can enhance disease prevention strategies, particularly in precision medicine.

Genetic disorders, hereditary diseases, DNA mutations, gene therapy, genetic testing, chromosomal abnormalities, inherited conditions, genetic predisposition, genomics, personalized medicine, rare diseases, familial risk, genetic counseling, autosomal recessive, autosomal dominant, carrier screening, molecular genetics, gene editing, epigenetics, genetic markers.

#GeneticDisorders #HereditaryDiseases #DNAMutations #GeneTherapy #GeneticTesting #ChromosomalAbnormalities #InheritedConditions #GeneticPredisposition #Genomics #PersonalizedMedicine #RareDiseases #FamilialRisk #GeneticCounseling #AutosomalRecessive #AutosomalDominant #CarrierScreening #MolecularGenetics #GeneEditing #Epigenetics #GeneticMarkers

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: x-i.me/gennom1
Award registration: x-i.me/genreg2
Member Nomination: x-i.me/genmember
Member Registration: x-i.me/genreg1
For Enquiries: genetics@healthcarek.com


Get Connected Here
---------------------------------
---------------------------------

Pinterest: x-i.me/genpt
Twitter: x-i.me/gentw
Facebook: x-i.me/genfb
Instagram: x-i.me/genin
Youtube: x-i.me/genyt

Comments

Post a Comment

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
Post a Comment
Read more

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...
Post a Comment
Read more